Literature DB >> 33160563

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.

Anil Chauhan1, Amit Agarwal1, Nishant Jaiswal1, Meenu Singh2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33160563     DOI： 10.1016/S0140-6736(20)32271-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Prevalence of COVID-19 Vaccine Side Effects among Early-Vaccinated Healthcare Workers in Eastern Ethiopia.

Authors:  Godana Jarso; Wassie Gebi; Meyrema Abdo; Misgana Lemma; Endashaw Abebe; Bekana Lemessa; Biniyam Tefera Deressa
Journal:  Ethiop J Health Sci       Date:  2022-05

Review 2.  Advances in the design and development of SARS-CoV-2 vaccines.

Authors:  Xue-Liang Peng; Ji-Si-Yu Cheng; Hai-Lun Gong; Meng-Di Yuan; Xiao-Hong Zhao; Zibiao Li; Dai-Xu Wei
Journal:  Mil Med Res       Date:  2021-12-16

Review 3.  Viral Vector Vaccine Development and Application during the COVID-19 Pandemic.

Authors:  Shaofeng Deng; Hui Liang; Pin Chen; Yuwan Li; Zhaoyao Li; Shuangqi Fan; Keke Wu; Xiaowen Li; Wenxian Chen; Yuwei Qin; Lin Yi; Jinding Chen
Journal:  Microorganisms       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.